ArticleInterface focus2017

Development of proteolytically stable N-methylated peptide inhibitors of aggregation of the amylin peptide implicated in type 2 diabetes.

Idira Obasse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.